| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/22/2011 | US7910661 Thiol-selective water-soluble polymer derivatives |
| 03/22/2011 | US7910618 Polyethylene glycol end-modified by an antibody or maleimide group on one end and a hydroxy fatty acid on the other; increased in vivo half life of insulin; antidiabetic agents |
| 03/22/2011 | US7910594 Antiproliferative agents; gene overexpression |
| 03/22/2011 | US7910562 Method of delivering genes into antigen presenting cells of the skin |
| 03/22/2011 | US7910554 Biodrugs comprising polypeptides and carriers comprising bioadhesives such as fibrin, for treatment of vision defects; chimeric C3-like Rho antagonists and their use for promoting repair and neuron survival in injured mammalian central and peripheral nervous system and for treating cancer |
| 03/22/2011 | US7910140 Heating plant extracts such as lupulone and propylene glycol, then adding group IA hydroxides and cooling to form solutions used as bactericides or microbiocides; biological antigrowth agents |
| 03/22/2011 | US7910133 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 03/22/2011 | US7910132 Pharmaceutical composition for the treatment of acute disorders |
| 03/22/2011 | US7910090 Non-irritating compositions |
| 03/22/2011 | US7910088 Multivalent constructs for therapeutic and diagnostic applications |
| 03/22/2011 | CA2553381C Compositions for localized therapy of the eye, comprising preferably triamcinolone acetonide and hyaluronic acid |
| 03/22/2011 | CA2484275C Warming and nonirritating lubricant compositions and method of comparing irritation |
| 03/22/2011 | CA2480273C Ph-sensitive polymer |
| 03/22/2011 | CA2473885C Use of ambroxol in the treatment of chronic pains, cerebral excitotoxicity-related disorders and cardiac arrhythmias |
| 03/22/2011 | CA2471769C Oral insulin therapy |
| 03/22/2011 | CA2464735C An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease |
| 03/22/2011 | CA2455939C Sucralose formulations to mask unpleasant tastes |
| 03/22/2011 | CA2452330C Controlled agglomeration |
| 03/22/2011 | CA2442960C Vessel sealing instrument |
| 03/22/2011 | CA2406201C Improvements in or relating to formulations for use in inhaler devices |
| 03/22/2011 | CA2386027C Biodegradable carrier systems for therapeutically active substances and process for their production |
| 03/22/2011 | CA2379357C Temperature-sensitive polymer/nanoshell composites for photothermally modulated drug delivery |
| 03/22/2011 | CA2362937C Taxane derivatives for targeted therapy of cancer |
| 03/22/2011 | CA2359334C Bifidobacterium in the treatment of inflammatory disease |
| 03/22/2011 | CA2317921C Preparation of a lipid blend and a phospholipid suspension containing the lipid blend |
| 03/22/2011 | CA2308127C Agonist and antagonist peptides of carcinoembryonic antigen (cea) |
| 03/22/2011 | CA2304808C Liquid interferon-.beta. formulations |
| 03/22/2011 | CA2173750C Single-chain forms of the glycoprotein hormone quartet |
| 03/17/2011 | WO2011032022A1 Improved pseudomonas exotoxin a with reduced immunogenicity |
| 03/17/2011 | WO2011031996A2 Engineered microparticles for macromolecule delivery |
| 03/17/2011 | WO2011031849A2 Anionic lipids and lipid nanostructures and methods of producing and using same |
| 03/17/2011 | WO2011031621A2 High strength seamless alginate capsules |
| 03/17/2011 | WO2011031617A2 Seamless alginate capsules |
| 03/17/2011 | WO2011031476A2 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation |
| 03/17/2011 | WO2011031462A2 Compositions for delivery of insoluble agents |
| 03/17/2011 | WO2011031441A1 Therapy with a chimeric molecule and a pro-apoptotic agent |
| 03/17/2011 | WO2011031284A1 Polymeric carrier compositions for the delivery of active agents, methods of making and using the same |
| 03/17/2011 | WO2011031176A1 Oral suspension formulations of esclicarbazepine acetate |
| 03/17/2011 | WO2011031116A2 Pad for herbal medicine in which release of medicinal ingredient can be controlled, and manufacturing method thereof |
| 03/17/2011 | WO2011031018A2 Water-soluble drug delivery system allowing slow release |
| 03/17/2011 | WO2011030952A1 Aqueous composition for enteric hard capsules, production method for enteric hard capsules and enteric hard capsules |
| 03/17/2011 | WO2011030946A1 Nano-hybrid of targetable sirna-layered inorganic hydroxide, manufacturing method thereof, and pharmaceutical composition for treating tumor comprising the nano-hybrid |
| 03/17/2011 | WO2011030682A1 Construct coated with virus coat-constituting protein and method for producing same |
| 03/17/2011 | WO2011030659A1 Antacid and laxative tablet |
| 03/17/2011 | WO2011030044A1 Novel powdered polymer, preparation method thereof and use of same as a thickener |
| 03/17/2011 | WO2011029980A1 Therapeutic compositions for the treatment of hpv-induced diseases |
| 03/17/2011 | WO2011029870A1 Use of interleukin-1 beta mutein conjugates in the treatment of diabetes |
| 03/17/2011 | WO2011029867A1 Implantable bio-resorbable polymer |
| 03/17/2011 | WO2010143827A3 Oil-gel soft patch for attachment to the skin and method for preparing same |
| 03/17/2011 | WO2010123563A3 Controlled release dispensing device |
| 03/17/2011 | WO2010111215A4 Compositions and methods for treatment of hemorrhage |
| 03/17/2011 | US20110066251 Anti-angiogenic compositions and methods of use |
| 03/17/2011 | US20110065862 Thioester-Terminated Water Soluble Polymers and Method of Modifying the N-Terminus of a Polypeptide Therewith |
| 03/17/2011 | US20110065810 Use of Alternan as Texturizing Agent in Foodstuffs and Cosmetics |
| 03/17/2011 | US20110065809 Polymerization of Multifunctional Azides, and Polymers Therefrom |
| 03/17/2011 | US20110065808 Carbonyl compound remover |
| 03/17/2011 | US20110065807 Ph sensitive biodegradable polymeric particles for drug delivery |
| 03/17/2011 | US20110065788 Aqueous formulations of (2-hydroxymethyl-indanyl-4-oxy)-phenyl-4,4,4-trifluorobutane-1-sulfonate |
| 03/17/2011 | US20110065770 Formulations comprising antisense nucleotides to connexins |
| 03/17/2011 | US20110065763 Compositions for Topical Application Having Androgenic Actions |
| 03/17/2011 | US20110065746 Composition of solifenacin or salt thereof for use in solid formulation |
| 03/17/2011 | US20110065742 Immediate release compositions and methods for delivering drug formulations using weak acid ion exchange resins in abnormally high PH environments |
| 03/17/2011 | US20110065677 Methods of Treating Inflammation with Compositions Comprising Lecithin Oils and NSAIDS for Protecting the Gastrointestinal Tract and Providing Enhanced Therapeutic Activity |
| 03/17/2011 | US20110065627 Transdermal delivery of medicaments with combinations of cetylated fatty fatty ester penetrant complexes |
| 03/17/2011 | US20110065587 Epitope testing using soluble hla |
| 03/17/2011 | US20110065185 Mutated anti-cd22 antibodies with increased affinity to cd22-expressing leukemia cells |
| 03/17/2011 | US20110064794 Drug Delivery System, its Preparation Process and Use |
| 03/17/2011 | US20110064791 Self forming, thermodynamically stable liposomes and their applications |
| 03/17/2011 | US20110064771 Plant extracts and uses thereof |
| 03/17/2011 | US20110064753 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease |
| 03/17/2011 | US20110064734 Prevention and treatment of amyloidogenic disease |
| 03/17/2011 | US20110064690 Pegylated Interleukin-10 |
| 03/17/2011 | US20110064667 Azide modified proteins |
| 03/17/2011 | US20110064664 Methods and compositions involving chitosan nanoparticles |
| 03/17/2011 | US20110064652 Nanoparticles for targeted delivery of active agents to the lung |
| 03/17/2011 | US20110061651 Formoterol superfine formulation |
| 03/17/2011 | DE19626431B4 Verwendung einer pharmazeutische Komposition mit antialkoholischer und nootroper Wirkung Use of a pharmaceutical composition with anti alcoholic and nootropic effect |
| 03/17/2011 | CA2809819A1 Extracellular targeted drug conjugates |
| 03/17/2011 | CA2773737A1 Anionic-core composition for delivery of therapeutic agents, and methods of making and using the same |
| 03/17/2011 | CA2773690A1 Protein matrix vaccines of improved immunogenicity |
| 03/17/2011 | CA2773665A1 Improved pseudomonas exotoxin a with reduced immunogenicity |
| 03/17/2011 | CA2773499A1 Implantable bio-resorbable polymer |
| 03/17/2011 | CA2773494A1 Actriib antagonists and dosing and uses thereof |
| 03/17/2011 | CA2773249A1 Oral suspension formulations of esclicarbazepine acetate |
| 03/17/2011 | CA2772750A1 Antacid and laxative tablet |
| 03/17/2011 | CA2772067A1 Methods and compositions for delivering interleukin-1 receptor antagonist |
| 03/16/2011 | EP2295971A2 Conjugate probes and optical detection of analytes |
| 03/16/2011 | EP2295578A2 Cyp1b1 nucleic acids and methods of use |
| 03/16/2011 | EP2295480A1 Implantable bio-resorbable polymer |
| 03/16/2011 | EP2295469A2 Monoclonal antibodies against claudin-18 for treatment of cancer |
| 03/16/2011 | EP2295456A1 Albumin fusion proteins |
| 03/16/2011 | EP2295450A1 Pegylated interleukin-10 |
| 03/16/2011 | EP2295407A1 Hydrazine-based and carbonyl-based bifunctional crosslinking reagents |
| 03/16/2011 | EP2295062A1 The use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis |
| 03/16/2011 | EP2295058A1 Depot formulations of iloperidone with a polymer |
| 03/16/2011 | EP2295045A1 Nanoparticles for nucleic acid delivery |
| 03/16/2011 | EP2294210A2 Efficient wellbeing assessment and improved treatment protocol |
| 03/16/2011 | EP2294126A1 Injectable hydrogel forming chitosan mixtures |
| 03/16/2011 | EP2294099A1 Oral galenic form, polymer production method and use of same |
| 03/16/2011 | EP2293819A1 Method for diagnosing cancers expressing the her2 receptor or its truncated variants |